• Login
    View Item 
    •   SAMRC InfoSpace Home
    • Intra-Mural Research Outputs
    • Intra Mural: Journal Articles
    • View Item
    •   SAMRC InfoSpace Home
    • Intra-Mural Research Outputs
    • Intra Mural: Journal Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Effect of metformin therapy and dietary supplements on semen parameters in hyperinsulinaemic males.

    Thumbnail
    View/Open
    Main Article (106.8Kb)
    Date
    2015-11
    Author
    Bosman, E
    Esterhuizen, A D
    Rodrigues, F A
    Becker, P J
    Hoffmann, W A
    Metadata
    Show full item record
    Abstract
    Previous reports indicated that hyperinsulinaemic men may exhibit a higher percentage of poorly compacted DNA in their spermatozoa and less success in an IVF programme (Andrologia, 45, 2003, 18; Andrologia, 2014, doi: 10.1111/and.12227). The aim of this study was to investigate the effect of metformin (Glucophage(®) ) and antioxidant treatment (StaminoGro(®) ) on the semen parameters of hyperinsulinaemic men. Nineteen hyperinsulinaemic male patients were treated for 3 months with metformin alone (Group A), and fifteen patients used metformin in combination with the nutritional supplement (Group B). Combined data of the two groups (pre- and post-treatment) differ significantly regarding sperm morphology (P = 0.0003) and CMA3 (P < 0.0001) values. The improvement in sperm morphology after treatment was similar for the two respective groups (P < 0.05). The morphological normal sperm forms increased from the mean percentage of 3.9 to 5.5% and from 4.2 to 5.5% for Group A and B respectively. Where a combination of metformin and the supplement were used (Group B), the combination treatment proved to be superior in obtaining enhanced chromatin packaging quality although not statistically significant (P = 0.5929) when compared with the metformin (Group A) group. The chromatin packaging quality in Group B improved with 10% while the improvement in Group A was approximately 8.3%. Therefore, infertile hyperinsulinaemic men can benefit from metformin treatment and should be advised on the use of nutritional supplements with antioxidant properties.
    URI
    http://hdl.handle.net/11288/595090
    Collections
    • Intra Mural: Journal Articles

    Browse

    All of SAMRC InfoSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2023  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV